Literature DB >> 30035171

NEO212: sub-cytotoxic doses capable of inhibiting glioma stem cell invasion.

Nagore I Marín-Ramos1, Florence M Hofman1, Thomas C Chen1.   

Abstract

Entities:  

Keywords:  NEO212; glioblastoma; glioma stem cells (GSC); invasion; temozolomide (TMZ)

Year:  2018        PMID： 30035171      PMCID： PMC6049296          DOI： 10.18632/oncoscience.429

Source DB:  PubMed          Journal:  Oncoscience        ISSN： 2331-4737


× No keyword cloud information.
  8 in total

Review 1.  Glioblastoma multiforme: emerging treatments and stratification markers beyond new drugs.

Authors:  C von Neubeck; A Seidlitz; H H Kitzler; B Beuthien-Baumann; M Krause
Journal:  Br J Radiol       Date:  2015-07-10       Impact factor: 3.039

2.  A novel temozolomide analog, NEO212, with enhanced activity against MGMT-positive melanoma in vitro and in vivo.

Authors:  Thomas C Chen; Hee-Yeon Cho; Weijun Wang; Jenny Nguyen; Niyati Jhaveri; Rachel Rosenstein-Sisson; Florence M Hofman; Axel H Schönthal
Journal:  Cancer Lett       Date:  2014-12-15       Impact factor: 8.679

3.  NEO212 Inhibits Migration and Invasion of Glioma Stem Cells.

Authors:  Nagore I Marín-Ramos; Thu Zan Thein; Hee-Yeon Cho; Stephen D Swenson; Weijun Wang; Axel H Schönthal; Thomas C Chen; Florence M Hofman
Journal:  Mol Cancer Ther       Date:  2018-02-13       Impact factor: 6.261

4.  A novel drug conjugate, NEO212, targeting proneural and mesenchymal subtypes of patient-derived glioma cancer stem cells.

Authors:  Niyati Jhaveri; Fabienne Agasse; Don Armstrong; Lilei Peng; Deborah Commins; Weijun Wang; Rachel Rosenstein-Sisson; Vijaya Pooja Vaikari; Shayane V Santiago; Tiago Santos; Ligang Chen; Axel H Schönthal; Thomas C Chen; Florence M Hofman
Journal:  Cancer Lett       Date:  2015-12-09       Impact factor: 8.679

5.  NEO212, temozolomide conjugated to perillyl alcohol, is a novel drug for effective treatment of a broad range of temozolomide-resistant gliomas.

Authors:  Hee-Yeon Cho; Weijun Wang; Niyati Jhaveri; David Jungpa Lee; Natasha Sharma; Louis Dubeau; Axel H Schönthal; Florence M Hofman; Thomas C Chen
Journal:  Mol Cancer Ther       Date:  2014-07-03       Impact factor: 6.261

6.  A novel temozolomide-perillyl alcohol conjugate exhibits superior activity against breast cancer cells in vitro and intracranial triple-negative tumor growth in vivo.

Authors:  Thomas C Chen; Hee-Yeon Cho; Weijun Wang; Manasi Barath; Natasha Sharma; Florence M Hofman; Axel H Schönthal
Journal:  Mol Cancer Ther       Date:  2014-03-12       Impact factor: 6.261

7.  Identification of human brain tumour initiating cells.

Authors:  Sheila K Singh; Cynthia Hawkins; Ian D Clarke; Jeremy A Squire; Jane Bayani; Takuichiro Hide; R Mark Henkelman; Michael D Cusimano; Peter B Dirks
Journal:  Nature       Date:  2004-11-18       Impact factor: 49.962

Review 8.  Chemoresistance of glioblastoma cancer stem cells--much more complex than expected.

Authors:  Dagmar Beier; Joerg B Schulz; Christoph P Beier
Journal:  Mol Cancer       Date:  2011-10-11       Impact factor: 27.401
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.